Short-Term Debt to Capital: Masimo Corp (MASI)

Corporate company logo of Masimo Corporation (MASI)

Masimo Corporation (MASI) relies on its own manufacturing plants in North America to create a closed-loop monitoring system, where unique sensors ensure complete clinic lock-in to the brand. This chart on GURU.Markets serves as an indicator of this model, reaching a value of 0.01. However, profits are being pressured by costly patent litigation, a reduction in government procurement, and merger errors within the consumer segment.

MASI - Masimo Corp Short-Term Debt to Capital Coefficient over the range 07/04/2022 - 06/21/2026

Analytical breakdowns for Masimo Corporation

- stock quotes and analyst forecast:
Stock Price Masimo Personal Health|MASI - Average Forecast Price
- company stock exchange capitalization indicators:
Market Capitalization Masimo Corp|MASI - Business Value
- book capitalization information:
Book Value per Share Masimo|MASI - Book Valuation of Business|Market Capitalization to Book Value Ratio masimo.com|MASI - Cumulative Company Assets
- business debt structure and liquidity details:
Total Debt to Capital Masimo Corporation|MASI - Long-Term Debt to Capital|Short-Term Debt to Equity Masimo|MASI - Company Debts|Debt to Book Value Masimo Corp|MASI - Company Long-Term Loans and Borrowings|Company Short-Term Debts Masimo|Quick Liquidity masimo.com
- earnings and market ratios statistics:
MASI - Company Profit
General company analysis:Masimo Personal Health MASI
Brand item of Masimo

Amidst intense patent battles with tech giants, Masimo Corporation (MASI) must maintain high liquidity to protect its technologies. This indicator measures the share of all credit obligations maturing within one year relative to equity, allowing for an assessment of short-term solvency risk. A decrease in the ratio of current liabilities under one year to equity minimizes the probability of asset drawdowns, thereby protecting the investment portfolio.

Direct competitors

Short-Term Debt to Capital ISRG|DHR - Current Liabilities to Capital|Short-Term Debt to Capital BDX (Becton Dickinson & Co)|STE: Short-Term Debt to Capital Ratio|West Pharmaceutical Services, Inc. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Baxter International Inc. BAX|STVN: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Teleflex Corp|MMSI (Merit Medical Systems) - Short-Term Debt to Capital|Short-Term Debt to Capital envistaco.com|Short-Term Debt to Equity ICU Medical (ICUI)|Short-Term Debt to Equity XRAY (Dentsply Sirona Inc)|LeMaitre - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ATRC|STAAR Surgical Company - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient ChromaDex Corp NAGE|ZimVie (ZIMV) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio ANGO|Short-Term Debt to Equity Cerus Corp|Teknova Inc (TKNO) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio MGRM (Monogram Technologies)|Short-Term Loans to Capital Ratio STSS|Short-Term Debt to Equity InfuSystem Holdings, Inc. INFU|Ratio of Short-Term Indebtedness to Capital UTMD|KRMD: Short-Term Debt to Equity Ratio|NYXH - Short-Term Debt to Capital|Microbot Medical Inc. (MBOT) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio pro-dex.com|ZTEK (Zentek) - Short-Term Debt to Capital|Current Liabilities to Capital Elutia Inc ELUT|Short-Term Debt to Equity Milestone Scientific Corp (MLSS)|NEXGEL Inc - Short-Term Debt to Capital Ratio|Retractable Technologies, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio HBIO (Harvard Bioscience Inc.)|FEMY - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient MeihuaMed MHUA|predictive-oncology.com (POAI) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Callan JMB|ATRI (Atrion Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital neurometrix.com